EE Impact

Ambu

Denmark · Pharma & Healthcare

LeaveRussia detail: Exit Completed

Exited Russia

Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services. It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse.

Status last verified 03/08/2026Source checked 30/09/2025Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 10/07/2025 · Reference ↗

It’s a legal battle for pharmaceutical company Ambu to liquidate its subsidiary in Russia, but CEO Britt Meelby Jensen remains confident that it will be accomplished before the New Year (2024). "Ambu is in the process of formally liquidating our Russian subsidiary. We did not sell or promote any products in Russia during the 2023/24 financial year, and we have no plans to do so in the future," the company said in its annual report. 10.07.2025: The legal entity AMBU LLC was liquidated.

Local stats (LeaveRussia)

Staff(RF), 2021
2

Status history since 2022

  1. 03/08/2026 exited · Imported from KSE LeaveRussia

Possible sanctions matches

Name-based matches against EU/US/UK lists — verify identity before drawing conclusions.

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.